These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23237397)

  • 1. [New class III antiarrhythmic drugs for treatment of atrial fibrillation].
    Maĭkov EB
    Kardiologiia; 2012; 52(11):56-65. PubMed ID: 23237397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
    Hanley CM; Robinson VM; Kowey PR
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We?
    El-Haou S; Ford JW; Milnes JT
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):412-31. PubMed ID: 25978691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the investigational antiarrhythmic agent dronedarone.
    Tafreshi MJ; Rowles J
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):15-26. PubMed ID: 17495254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial fibrillation: where is the border between pure antiarrhythmic and non-antiarrhythmic medicines?].
    Moiseev SV
    Kardiologiia; 2012; 52(2):85-90. PubMed ID: 22799018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation.
    Dobrev D
    J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of new III class antiarrhythmic drug Niferidil (RG-2) on bioelectrical activity of rat pulmonary veins myocardium].
    Egorov IuV; Stolbova VI; Kuz'min VS; Rozenshtraukh LV
    Kardiologiia; 2012; 52(2):47-51. PubMed ID: 22792739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in atrial antiarrhythmic drug therapy.
    Burashnikov A; Antzelevitch C
    Nat Rev Cardiol; 2010 Mar; 7(3):139-48. PubMed ID: 20179721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
    Aguilar M; Nattel S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
    Lévy S; Ricard P; Yapo F; Mansouri C
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of atrial fibrillation: future directions.
    Page RL
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S91-4. PubMed ID: 17336894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].
    Ravens U; Wettwer E; Schotten U; Wessel R; Dobrev D
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):64-72. PubMed ID: 16786464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New directions in antiarrhythmic drug therapy for atrial fibrillation.
    Heijman J; Voigt N; Dobrev D
    Future Cardiol; 2013 Jan; 9(1):71-88. PubMed ID: 23259476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of atrial fibrillation and action of drugs used in its management.
    Grant AO
    Am J Cardiol; 1998 Oct; 82(8A):43N-49N. PubMed ID: 9809900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
    Nattel S; Dobrev D
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
    [No Abstract]   [Full Text] [Related]  

  • 19. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug therapy for atrial fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Cardiol Clin; 2014 Nov; 32(4):533-49. PubMed ID: 25443235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.